Submitted by Anonymous (not verified) on 3 November 2023 - 14:50
Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 05/11/2020, Revision: 7, Status: Authorised
Source: